Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
Antimicrobial Agents and Chemotherapy|July 26, 2021
Phenotypic/Genotypic Profile of OXA-10-Like-Harboring, Carbapenem-Resistant Pseudomonas aeruginosa: Using Validated Pharmacokinetic/Pharmacodynamic <i>In Vivo</i> Models To Further Evaluate Enzyme Functionality and Clinical ImplicationsChristian M Gill, Adrian Brink, Chun Yat Chu, et al.
Jac-Antimicrobial Resistance|March 8, 2024
A multicentre evaluation of the NG-test DetecTool OXA-23 for the rapid detection of OXA-23 carbapenemase directly from blood culturesAlexandra Vasilakopoulou, Thierry Naas, Camille Gonzalez, et al.
Antimicrobial Agents and Chemotherapy|May 19, 2025
Characterization of genome-wide transpositions induced by colistin exposure in multi-drug-resistant <i>Klebsiella pneumoniae</i>Sahaya Glingston Rajakani, Basil Britto Xavier, Ngoc Minh Nguyen, et al.
Rheumatology (Oxford, England)|May 25, 2023
Sustained cell-mediated but not humoral responses in rituximab-treated rheumatic patients after vaccination against SARS-CoV-2Κonstantinos Thomas, Ioannis Grigoropoulos, Panagiota Alexopoulou, et al.
Transplantation and Cellular Therapy|March 30, 2026
Rectal colonization with multidrug-resistant organisms and subsequent bloodstream infections in hematological patients undergoing cellular therapiesPinelopi Kazakou, Charalampos Charalampidis, Ioannis Konstantellos, et al.
JAMA|April 18, 2026
Fast Antimicrobial Susceptibility Testing for Gram-Negative Bacteremia: The FAST Randomized Clinical TrialRitu Banerjee, Lauren Komarow, Yixuan Li, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2021
Elevated MICs of Susceptible Antipseudomonal Cephalosporins in Non-Carbapenemase-Producing, Carbapenem-Resistant Pseudomonas aeruginosa: Implications for Dose OptimizationChristian M Gill, Elif Aktaş, Wadha Alfouzan, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 22, 2021
The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosaChristian M Gill, Elif Aktaþ, Wadha Alfouzan, et al.
Open Forum Infectious Diseases|February 2, 2022
Multicenter, Prospective Validation of a Phenotypic Algorithm to Guide Carbapenemase Testing in Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Using the ERACE-PA Global Surveillance ProgramChristian M Gill, Elif Aktaþ, Wadha Alfouzan, et al.
Journal of Clinical Microbiology|May 25, 2023
Multicenter Evaluation of the BIOFIRE Blood Culture Identification 2 Panel for Detection of Bacteria, Yeasts, and Antimicrobial Resistance Genes in Positive Blood Culture SamplesDaniel D Rhoads, Spyros Pournaras, Amy Leber, et al.
Pageof 18